- Home
- PRE vs ONCY Comparison
PRE vs ONCY Comparison
Compare PRE & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- ONCY
- Stock Information
- Founded
- PRE 2014
- ONCY 1998
- Country
- PRE Hong Kong
- ONCY Canada
- Employees
- PRE N/A
- ONCY N/A
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- ONCY Pharmaceuticals and Biotechnology
- Sector
- PRE Industrials
- ONCY Health Care
- Exchange
- PRE Nasdaq
- ONCY Nasdaq
- Market Cap
- PRE 72.6M
- ONCY 86.1M
- IPO Year
- PRE N/A
- ONCY 1999
- Fundamental
- Price
- PRE $5.53
- ONCY $0.74
- Analyst Decision
- PRE Buy
- ONCY Strong Buy
- Analyst Count
- PRE 1
- ONCY 2
- Target Price
- PRE $9.00
- ONCY $4.00
- AVG Volume (30 Days)
- PRE 13.0K
- ONCY 359.4K
- Earning Date
- PRE 11-27-2024
- ONCY 11-12-2024
- Dividend Yield
- PRE N/A
- ONCY N/A
- EPS Growth
- PRE N/A
- ONCY N/A
- EPS
- PRE N/A
- ONCY N/A
- Revenue
- PRE $25,561,362.00
- ONCY N/A
- Revenue This Year
- PRE $64.44
- ONCY N/A
- Revenue Next Year
- PRE $154.24
- ONCY N/A
- P/E Ratio
- PRE N/A
- ONCY N/A
- Revenue Growth
- PRE N/A
- ONCY N/A
- 52 Week Low
- PRE $2.85
- ONCY $0.76
- 52 Week High
- PRE $7.84
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- PRE 66.84
- ONCY 26.96
- Support Level
- PRE $5.06
- ONCY $0.91
- Resistance Level
- PRE $5.35
- ONCY $0.88
- Average True Range (ATR)
- PRE 0.20
- ONCY 0.04
- MACD
- PRE 0.09
- ONCY -0.01
- Stochastic Oscillator
- PRE 94.44
- ONCY 11.12
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.